Redwood AI Corp. (CSE: AIRX) (OTCQB: RDWCF) has announced the signing of a non-binding letter of intent with Dr. Placide Sesonga of the University of Global Health Equity in Rwanda to explore the development of a regional pathogen tracking and AI-enabled outbreak intelligence initiative across Central and East Africa. The proposed collaboration would initially focus on surveillance regions and mobility corridors in Rwanda and the Democratic Republic of the Congo, combining pathogen monitoring, genomic sequencing, geospatial analytics and Redwood’s AI-driven predictive intelligence platform to support earlier detection of emerging infectious disease threats.
The parties plan to develop project protocols, deployment frameworks and stakeholder engagement strategies while pursuing potential funding opportunities. This initiative comes at a time when global health security remains a pressing concern, particularly in regions with high mobility and limited surveillance infrastructure. By leveraging artificial intelligence to analyze pathogen data, the project aims to provide public health authorities with actionable insights that could enable faster responses to outbreaks.
Redwood AI uses advanced artificial intelligence to accelerate chemistry R&D, with the aim of assisting in drug discovery and development, and furthering defense and safety solutions. The company combines expertise in chemistry, AI, and manufacturing to streamline drug synthesis and scale-up. Its platform is designed to enable faster, more efficient development of new therapies and chemistry-driven applications. The pathogen surveillance initiative represents a strategic expansion of Redwood’s AI capabilities into public health, potentially creating new opportunities for the company in the growing field of digital health and pandemic preparedness.
In a separate announcement, Redwood AI disclosed the resignation of Graydon Bensler from its board of directors, effective immediately. The company did not provide further details regarding the resignation. For the full press release, visit https://ibn.fm/4ra9u.
The initiative underscores a growing trend of using AI and big data to enhance disease surveillance, particularly in regions where infectious diseases pose significant public health risks. If successful, the collaboration could serve as a model for other regions in Africa and beyond, demonstrating how technology can bridge gaps in healthcare infrastructure. The partnership with the University of Global Health Equity, a Rwandan institution focused on health equity, adds academic rigor and local expertise to the project. More information about Redwood AI is available in the company’s newsroom at https://ibn.fm/RDWCF.
The announcement comes amid increased global attention on pandemic prevention and response, following the COVID-19 pandemic. AI-powered surveillance systems are seen as a critical tool for identifying and containing outbreaks before they become widespread. Redwood AI’s entry into this space aligns with its broader mission to apply AI to real-world challenges.
This news story relied on content distributed by InvestorBrandNetwork (IBN). Blockchain Registration, Verification & Enhancement provided by NewsRamp™. The source URL for this press release is Redwood AI Signs Letter of Intent for AI-Enabled Pathogen Surveillance in East Africa.